Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure

NCT00016523 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

420

Enrollment

NETWORK

Sponsor class

Stopped Preliminary results showed increased intraventricular hemorrhage (IVH) in experimental arm

Conditions

Infant, Newborn
Infant, Low Birth Weight
Infant, Small for Gestational Age
Infant, Premature
Respiratory Distress Syndrome (RDS)
Sepsis
Pneumonia
Hypertension, Pulmonary

Interventions

DRUG: Inhaled nitric oxide
DRUG: Placebo

Sponsor

NICHD Neonatal Research Network

Collaborators

[object Object]